These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35150649)

  • 1. Seeing C diff differently.
    Stephenson AL
    Lancet Gastroenterol Hepatol; 2022 Mar; 7(3):207. PubMed ID: 35150649
    [No Abstract]   [Full Text] [Related]  

  • 2. 'Game changer' antibiotic and others in works for superbug.
    Dolgin E
    Nat Med; 2011 Jan; 17(1):10. PubMed ID: 21217660
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.
    Johnson S; Gerding DN; Louie TJ; Ruiz NM; Gorbach SL
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4043-5. PubMed ID: 22615287
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing Clostridium difficile in inflammatory bowel disease (IBD).
    Hashash JG; Binion DG
    Curr Gastroenterol Rep; 2014; 16(7):393. PubMed ID: 24838421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronidazole and vancomycin: equivalence of initial efficacy in CDAD.
    Burman LG
    Am J Gastroenterol; 2008 Aug; 103(8):2147; author reply 2147. PubMed ID: 18796117
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ; Wilcox MH
    Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium difficile infection.
    Kuipers EJ; Surawicz CM
    Lancet; 2008 May; 371(9623):1486-8. PubMed ID: 18456087
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
    Mathur H; O'Connor PM; Hill C; Cotter PD; Ross RP
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2882-6. PubMed ID: 23571539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting the challenge of recurrent Clostridium difficile infection.
    Johnson S
    J Hosp Med; 2012 Mar; 7 Suppl 3():S11-3. PubMed ID: 22407994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
    Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
    Gerding DN
    Clin Infect Dis; 2005 Jun; 40(11):1598-600. PubMed ID: 15889356
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes from rectal vancomycin therapy in patients with Clostridium difficile infection.
    Saffouri G; Khanna S; Estes L; Pardi D
    Am J Gastroenterol; 2014 Jun; 109(6):924-5. PubMed ID: 24896763
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Clostridium difficile diarrhea.
    Med Lett Drugs Ther; 1989 Oct; 31(803):94-5. PubMed ID: 2796843
    [No Abstract]   [Full Text] [Related]  

  • 15. Clostridium difficile bacteremia, Taiwan.
    Lee NY; Huang YT; Hsueh PR; Ko WC
    Emerg Infect Dis; 2010 Aug; 16(8):1204-10. PubMed ID: 20678312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
    Pakyz AL; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Infect Control Hosp Epidemiol; 2010 Aug; 31(8):867-8. PubMed ID: 20586649
    [No Abstract]   [Full Text] [Related]  

  • 17. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Bartlett JG
    Clin Infect Dis; 2008 May; 46(10):1489-92. PubMed ID: 18419480
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.
    Wenisch JM; Schmid D; Kuo HW; Allerberger F; Michl V; Tesik P; Tucek G; Laferl H; Wenisch C
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1974-8. PubMed ID: 22252830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Clostridium difficile diarrhoea.
    Kyne L; Kelly CP
    Gut; 2001 Jul; 49(1):152-3. PubMed ID: 11413124
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection.
    Bossé D; Lemire C; Ruel J; Cantin AM; Ménard F; Valiquette L
    Infection; 2013 Apr; 41(2):579-82. PubMed ID: 22996384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.